With over three decades of leadership in the life sciences and healthcare sectors, Al is a strategic business builder who has played pivotal roles in driving corporate growth, executing high-value transactions, and navigating challenging business environments and complex legal and regulatory landscapes. As a business owner and former executive for publicly traded companies ranging in size from the Fortune 125 to small cap, Al has worked extensively with boards and management teams to increase shareholder value by successfully traversing complex matters including large scale M&A transactions, equity capital raises and debt financings, shareholder activism challenges, new product launches, high-stakes litigation, cybersecurity breaches, and enterprise risk management on a global scale. After more than two decades in senior positions at major corporations and law firms, Al founded and has led GC Legal Advisors, an innovative consultancy focused on advising and supporting the boards and executive teams of life sciences companies, since 2010. While leading the firm, he has periodically stepped away from day-to-day management to assume key C-suite roles with certain companies at critical times of their growth and evolution, driving a series of successful exits. These roles have included COO at a Nasdaq-listed molecular diagnostic company and CEO of a subsidiary business, CLO and Corporate Secretary of a therapeutics firm where he led its acquisition by a larger publicly traded company, and CLO and Corporate Secretary of the global pharmaceutical subsidiary of a publicly traded Japanese conglomerate.